Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies

Document Type

Abstract

Publication Date

10-20-2023

Keywords

oregon; chiles

Clinical Institute

Cancer

Specialty/Research Institute

Oncology

Specialty/Research Institute

Hematology

Comments

Garmezy B, Kambhampati S, Curti B, Reimers M, Caimi P, Diefenbach C, Heath E, Jonasch E, Park S, Kornblum N, Li W, Li N, Spurgeon S, Vaishampayan UN, Ye D, Zhang L, Zhao W, Chen Z, Hunder N, Ma S, Song E, Call JA. SITC Annual Meeting; November 1-5; San Diego, CA. 2023;11(Suppl 1): 718.

This document is currently not available here.

Providence Full Text

Share

COinS